Arnold Lippa Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Arnold Lippa.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Arnold Lippa. Arnold Lippa is Chairman, CEO & President in RespireRx Pharmaceuticals Inc. ($RSPI) and Exec Chairman, CSO in RespireRx Pharmaceuticals Inc. ($RSPI) and Exec. Chairman & CSO in RespireRx Pharmaceuticals Inc. ($RSPI) and Exec. Chairman and CSO in RespireRx Pharmaceuticals Inc. ($RSPI) and Exec. Chairman, CEO & CSO in RespireRx Pharmaceuticals Inc. ($RSPI) and Exec. Chairman, CEO, CSO in RespireRx Pharmaceuticals Inc. ($RSPI) and Executive Chairman & CSO in RespireRx Pharmaceuticals Inc. ($RSPI) and Executive Chairman and CSO in RespireRx Pharmaceuticals Inc. ($RSPI) and Director in Euthymics Bioscience Inc ($DOVP) and Director in ContraVir Pharmaceuticals, Inc. ($CTRV).
Latest Insider Trading Transactions of Arnold Lippa
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DOVP, HEPA, RSPI
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman & CS ... | Option Exercise | G | 0.01 | 100 | 1 | 0 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman & CS ... | Option Exercise | G | 0.01 | 100 | 1 | 0 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman & CS ... | Option Exercise | G | 0.01 | 100 | 1 | 0 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman & CS ... | Option Exercise | G | 0.01 | 100 | 1 | 0 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman & CS ... | Option Exercise | J | 0.01 | 100 | 1 | 100 | |
| Oct 02 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman & CS ... | Option Exercise | J | 0.01 | 100 | 1 | 100 | |
| Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | Lippa Arnold | Director | Option Exercise | A | 3.72 | 30,000 | 111,600 | 91,110 | |
| Jul 15 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman, CEO ... | Option Exercise | G | 0.01 | 600 | 4 | 0 | |
| Jul 15 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman, CEO ... | Option Exercise | G | 0.01 | 600 | 4 | 0 | |
| Jul 15 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman, CEO ... | Option Exercise | J | 0.01 | 600 | 4 | 600 | |
| Jul 15 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman, CEO ... | Option Exercise | G | 0.01 | 600 | 4 | 0 | |
| Jul 15 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman, CEO ... | Option Exercise | G | 0.01 | 600 | 4 | 0 | |
| Jul 15 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman, CEO ... | Option Exercise | J | 0.01 | 600 | 4 | 600 | |
| Apr 07 2020 | CTRV | Hepion Pharmaceuti ... | Lippa Arnold | Director | Option Exercise | A | 1.63 | 60,000 | 97,800 | 61,109 | |
| Mar 24 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman, CEO ... | Gift | G | 0.00 | 4,500,000 | 0 | 598 | 4.5 M to 598 (-99.99 %) |
| Mar 24 2020 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman, CEO ... | Buy | J | 0.00 | 4,500,000 | 0 | 4,500,598 | 598 to 4.5 M (+752,508.36 %) |
| Jul 25 2019 | CTRV | Hepion Pharmaceuti ... | Lippa Arnold | Director | Option Exercise | A | 3.24 | 970 | 3,143 | 1,109 | |
| Sep 14 2018 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec Chairman, CSO | Option Exercise | G | 1.58 | 47,620 | 75,002 | 0 | |
| Sep 14 2018 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec Chairman, CSO | Option Exercise | P | 1.58 | 47,620 | 75,002 | 47,620 | |
| Sep 14 2018 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec Chairman, CSO | Gift | G | 0.00 | 47,620 | 0 | 0 | 47.6 K to 0 (-100.00 %) |
| Sep 14 2018 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec Chairman, CSO | Buy | P | 0.00 | 47,620 | 0 | 47,620 | 0 to 47.6 K |
| Jul 03 2018 | CTRV | ContraVir Pharmace ... | Lippa Arnold | Director | Option Exercise | P | 1.55 | 8,625 | 13,369 | 8,625 | |
| Jul 03 2018 | CTRV | ContraVir Pharmace ... | Lippa Arnold | Director | Option Exercise | P | 1.55 | 15 | 23 | 15 | |
| Dec 12 2017 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec Chairman, CSO | Option Exercise | G | 1.45 | 559,595 | 811,413 | 0 | |
| Dec 12 2017 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec Chairman, CSO | Option Exercise | J | 1.45 | 559,595 | 811,413 | 559,595 | |
| Jul 05 2017 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | J | 2.00 | 50,000 | 100,000 | 0 | |
| Jul 05 2017 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | A | 2.00 | 50,000 | 100,000 | 50,000 | |
| Jan 20 2017 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | J | 3.90 | 50,000 | 195,000 | 0 | |
| Jan 20 2017 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | A | 3.90 | 50,000 | 195,000 | 50,000 | |
| Jul 20 2016 | CTRV | ContraVir Pharmace ... | Lippa Arnold | Director | Option Exercise | A | 1.04 | 32,500 | 33,800 | 77,500 | |
| Jun 20 2016 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | J | 0.02 | 24,000,000 | 544,800 | 0 | |
| Jun 20 2016 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | J | 0.02 | 10,000,000 | 197,000 | 0 | |
| Jun 20 2016 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | J | 0.03 | 15,000,000 | 375,000 | 0 | |
| Apr 04 2016 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | A | 0.02 | 24,000,000 | 544,800 | 24,000,000 | |
| Apr 04 2016 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Executive Chairman ... | Option Exercise | J | 0.02 | 3,350,319 | 52,600 | 3,350,319 | |
| Aug 20 2015 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Exec. Chairman and ... | Option Exercise | A | 0.02 | 10,000,000 | 197,000 | 10,000,000 | |
| Jul 06 2015 | RSPI | RespireRx Pharmace ... | Lippa Arnold | Chairman, CEO & Pre ... | Option Exercise | A | 0.03 | 15,000,000 | 375,000 | 15,000,000 | |
| May 20 2008 | DOVP | Euthymics Bioscien ... | Lippa Arnold | Director | Option Exercise | A | 0.00 | 127,000 | 0 | 387,000 | |
| May 20 2008 | DOVP | Euthymics Bioscien ... | Lippa Arnold | Director | Option Exercise | A | 0.00 | 260,000 | 0 | 387,000 | |
| May 20 2008 | DOVP | Euthymics Bioscien ... | Lippa Arnold | Director | Option Exercise | D | 0.00 | 407,600 | 0 | 387,000 | |
| Aug 13 2007 | DOVP | Euthymics Bioscien ... | Lippa Arnold | Director | Option Exercise | A | 0.30 | 127,000 | 38,100 | 407,600 | |
| Aug 13 2007 | DOVP | Euthymics Bioscien ... | Lippa Arnold | Director | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 |
Page: 1